(Q37352389)

19 August 2017

Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension (English)

1 reference

19 August 2017

arterial hypertension

0 references

1 reference

Ahmed A Elmarakby

1

1 reference

19 August 2017

Jan M Williams

2

1 reference

19 August 2017

John D Imig

3

1 reference

19 August 2017

Jennifer S Pollock

4

1 reference

19 August 2017

David M Pollock

5

1 reference

19 August 2017

26 September 2006

1 reference

19 August 2017

Vascular Pharmacology

1 reference

19 August 2017

46

1 reference

19 August 2017

2

1 reference

19 August 2017

144-151

1 reference

Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Role of oxidative stress in angiotensin-induced hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Role of superoxide in modulating the renal effects of angiotensin II.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Increased renal medullary H2O2 leads to hypertension

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Enalapril attenuates endothelin-1-induced hypertension via increased kinin survival

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

A mouse model of angiotensin II slow pressor response: role of oxidative stress

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Antioxidants block angiotensin II-induced increases in blood pressure and endothelin

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2746434

Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension

2 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Evidence for endothelin involvement in the response to high salt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Renal endothelin in chronic angiotensin II hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.09.004

The B1 receptors for kinins

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17112788

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2006.09.004

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

17112788

1 reference